Feb 11, 2026 04:57PM
Feb 11, 2026 07:00AM
Jan 20, 2026 04:15PM
Jan 12, 2026 07:15AM
Jan 12, 2026 07:15AM
Dec 11, 2025 10:12AM
Dec 4, 2025 07:10AM Royalty Pharma and Denali Therapeutics Announce $275 Million Royalty Funding Agreement
Dec 4, 2025 07:02AM
Dec 4, 2025 07:00AM
Nov 6, 2025 04:13AM
Nov 5, 2025 07:00AM
Oct 9, 2025 04:15PM
Aug 6, 2025 07:00AM
Jul 22, 2025 05:02AM Royalty Pharma (RPRX) PT Raised to $42 at Citi
Jul 16, 2025 04:15PM
May 16, 2025 04:30PM
May 8, 2025 07:15AM
Apr 17, 2025 04:15PM
Feb 11, 2025 07:54AM
Feb 11, 2025 07:15AM
Jan 28, 2025 04:15PM Royalty Pharma to Announce Fourth Quarter and Full Year 2024 Financial Results on February 11, 2025
Nov 6, 2024 07:15AM
Oct 16, 2024 04:15PM
Aug 8, 2024 07:00AM
Jul 19, 2024 08:15AM
May 23, 2024 11:48AM
May 9, 2024 07:00AM
May 9, 2024 06:45AM Royalty Pharma plc (RPRX) to Acquire Royalty Interest in Sanofi’s (SNY) Frexalimab
May 9, 2024 06:45AM
Apr 19, 2024 08:15AM
Feb 15, 2024 07:30AM
Jan 30, 2024 04:15PM
Nov 8, 2023 07:00AM
Oct 11, 2023 04:15PM
Aug 8, 2023 07:00AM Royalty Pharma Reports Second Quarter 2023 Results
Jul 18, 2023 04:15PM
May 9, 2023 07:57AM
May 9, 2023 07:00AM
Apr 13, 2023 09:01AM
Apr 13, 2023 09:01AM
Feb 15, 2023 07:00AM
Feb 15, 2023 07:00AM Royalty Pharma Reports Q4 and Full Year 2022 Results
Jan 18, 2023 08:25AM
Jan 18, 2023 08:25AM
Nov 8, 2022 07:28AM
Nov 8, 2022 07:00AM
Nov 8, 2022 07:00AM
Nov 7, 2022 04:05PM
Oct 18, 2022 08:30AM Royalty Pharma to Announce Third Quarter 2022 Financial Results on November 8, 2022
Oct 18, 2022 08:30AM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All